Product
Acne mRNA vaccine
1 clinical trial
1 indication
Indication
AcneClinical trial
A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of AgeStatus: Recruiting, Estimated PCD: 2027-12-22